Clinical Trials Directory

Trials / Completed

CompletedNCT04311723

Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial

Ventilatory Strategy to Prevent Atelectasis During Bronchoscopy Under General Anesthesia (VESPA Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This trial compares two different types of ventilation for the prevention of partial or complete collapsed lung (atelectasis) in patients undergoing bronchoscopy under general anesthesia. Ventilatory strategy to prevent atelectasis (VESPA) may work better than standard of care mechanical ventilation to reduce the intra-procedural development of atelectasis during bronchoscopy under general anesthesia.

Detailed description

PRIMARY OBJECTIVE: I. To determine if our ventilatory strategy to prevent atelectasis (VESPA) can reduce the intra-procedural development of atelectasis during bronchoscopy under general anesthesia when compared with conventional mechanical ventilation. SECONDARY OBJECTIVES: I. To describe proportion of VESPA-induced complications. II. To describe and compare proportion of bronchoscopy-induced complications in VESPA and control arms. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients receive anesthesia using a standard short breathing tube called laryngeal mask airway (LMA) and then undergo standard of care bronchoscopy. GROUP II: Patients receive anesthesia using a longer breathing tube called an endotracheal tube and then undergo standard of care bronchoscopy.

Conditions

Interventions

TypeNameDescription
PROCEDUREAnesthesia ProcedureReceive anesthesia using laryngeal mask
PROCEDUREAnesthesia ProcedureReceive anesthesia using endotracheal tube
PROCEDUREBronchoscopyUndergo standard of care bronchoscopy

Timeline

Start date
2020-05-27
Primary completion
2024-03-21
Completion
2024-03-21
First posted
2020-03-17
Last updated
2024-10-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04311723. Inclusion in this directory is not an endorsement.